BioCryst Pharmaceuticals Inc. (BCRX) Fundamentals

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
SHARE INFORMATION
Market Cap$ 2,298,280,398
Shares Outstanding185,945,016
Float165,782,775
Percent Float89.16%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 157,170,000
Latest Fiscal EPS$ -1.03
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions503
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months27,067,546
Institutional Holdings Percent118.6%
Institutional Sold Previous 3 Months14,786,926
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months476,691
Insider Holdings Percent2.9
Insider Sold Previous 3 Months-
Insider Shares Owned5,378,658
TRADING INFO
52 Week High$ 19.99
52 Week Low$ 7.61
52 Week High Change$ -14.05
21 Day Moving Average$ 13.2419
21 Day Extended Moving Average$ 13.0728
50 Day Moving Average$ 13.223
50 Day Extended Moving Average$ 12.9615
200 Day Moving Average$ 13.0829
200 Day Extended Moving Average$ 12.7199
10 Day Average Volume2,412,120
20 Day Average Volume2,442,795
30 Day Average Volume2,246,052
50 Day Average Volume2,540,674
Alpha0.021127
Beta2.0768
Standard Deviation0.222616
R20.221569
7 Day Price Change$ -0.34
7 Day Percent Change-2.68%
21 Day Price Change$ -1.37
21 Day Percent Change-9.98%
30 Day Price Change$ -1.59
30 Day Percent Change-11.4%
Month to Date Price Change$ -1.54
Month to Date Percent Change-11.08%
Quarter to Date Price Change$ 1.78
Quarter to Date Percent Change16.82%
180 Day Price Change$ -4.75
180 Day Percent Change-27.76%
200 Day Price Change$ -3.76
200 Day Percent Change-23.33%
Year to Date Price Change$ -1.49
Year to Date Percent Change-10.76%

BioCryst Pharmaceuticals Inc. (BCRX) Key Ratios

PROFITABILITY
EBIT Margin-61.6%
EBITDA Margin-61.1%
Pre-Tax Profit Margin-406.7%
Profit Margin Count-87.77%
Gross Margin99.3%
Profit Margin TOT-87.77%
INCOME STATEMENTS
Revenue$ 203,607,000
Revenue Per Share$ 1.095
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-11.30
Total Debt To Equity0.00
Int Coverage-1.60
Current Ratio5.20
Leverage Ratio-3.00
Quick Ratio4.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-11.20
Enterprise Value$ 2,135,915,156
Price to Sales11.2878
Price to Free Cash-14.70
PE High Last 5 Years-9.60
Price To Book56.60
Price To Cash Flow0.00
PE Low Last 5 Years-6.70
Price to Tangible Book-11.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover8.00
Invoice Turnover0.10
Assets Turnover0.50
Return Assets-55.49
Return on Equity136.58
Return on Capital-96.99

BioCryst Pharmaceuticals Inc. (BCRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJon P. Stonehouse
Emplyoees358
Last AuditUQ
CIK0000882796
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address4505 Emperor Boulevard
Suite 200
Durham, NC 27703
Websitehttp://www.biocryst.com
Facsimile+1 919 859-1314
Telephone+1 919 859-1302
Emailjbluth@biocryst.com


Your Recent History
NASDAQ
BCRX
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.